Please enable JavaScript to continue using this application.

Compare $HUMA vs $PMVP | Chartloom

Compare

$HUMA vs $PMVP

Humacyte Inc · PMV Pharmaceuticals Inc

HUMA

Humacyte Inc

PMVP

PMV Pharmaceuticals Inc

Compare $HUMA vs $PMVP

Comparing Humacyte Inc and PMV Pharmaceuticals Inc

HUMAHumacyte Inc

PMVPPMV Pharmaceuticals Inc

HUMAHumacyte Inc

Market cap

$109M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

14.62x

Rev growth (TTM)

159.3%

YTD performance

-58.4%

52W performance

-76.0%

FCF yield

-89.3%

PMVPPMV Pharmaceuticals Inc

Market cap

$81M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

23.6%

52W performance

7.0%

FCF yield

-87.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

HUMA

PMVP

Detailed metrics comparison

HUMA

Humacyte Inc

PMVP

PMV Pharmaceuticals Inc

Market Cap

HUMA$109M

PMVP$81M

Enterprise Value

HUMA$96M

PMVP$69M

Price

HUMA$0.41

PMVP$1.52

P/E Ratio

HUMAN/A

PMVPN/A

P/S Ratio

HUMA51.53x

PMVP0.00x

EV/Sales

HUMA45.06x

PMVP0.00x

EV/EBITDA

HUMA0.00x

PMVP0.00x

P/B Ratio

HUMA4.63x

PMVP1.89x

P/FCF Ratio

HUMAN/A

PMVPN/A

EV/FCF

HUMA-0.98x

PMVP-0.96x

PEG Ratio

HUMAN/A

PMVPN/A

Forward P/E (NTM)

HUMAN/A

PMVPN/A

Forward P/S (NTM)

HUMA14.62x

PMVPN/A

Revenue (TTM)

HUMA$2M

PMVP$0

Revenue Growth (YoY)

HUMA159.3%

PMVPN/A

Forward Rev Growth

HUMA520.3%

PMVP546.2%

Gross Margin (TTM)

HUMA-494.6%

PMVP0.0%

Operating Margin (TTM)

HUMA0.0%

PMVP0.0%

EBITDA Margin (TTM)

HUMA-4900.0%

PMVP0.0%

Net Margin (TTM)

HUMA-4560.8%

PMVP0.0%

FCF Margin (TTM)

HUMA-4599.7%

PMVPN/A

Net Income (TTM)

HUMA$-97M

PMVP$-75M

FCF (TTM)

HUMA$-98M

PMVP$-71M

EPS (TTM)

HUMA-$0.41

PMVP-$1.41

ROE (TTM)

HUMA-51675.0%

PMVP-7811.0%

ROA (TTM)

HUMA-8476.0%

PMVP-7013.0%

ROIC (TTM)

HUMA-9784.0%

PMVP-7811.0%

Cash

HUMA$80M

PMVP$12M

Debt

HUMA$66M

PMVP$0

Net Cash/Debt

HUMA$14M

PMVP$12M

Current Ratio (TTM)

HUMA6.21x

PMVP7.70x

Quick Ratio (TTM)

HUMA5.38x

PMVP7.52x

Debt/Equity (TTM)

HUMA2.12x

PMVP0.00x

Debt/Assets (TTM)

HUMA0.0%

PMVP0.0%

Interest Coverage (TTM)

HUMAN/A

PMVPN/A

Net Debt/EBITDA (TTM)

HUMA0.00x

PMVP0.00x

Beta

HUMA2.76

PMVP1.48

52W Performance

HUMA-76.0%

PMVP7.0%

YTD Performance

HUMA-58.4%

PMVP23.6%

% from 52W High

HUMA-78.6%

PMVP-20.4%

% from 52W Low

HUMA3.7%

PMVP49.0%

Asset Turnover (TTM)

HUMA0.02x

PMVP0.00x

FCF Yield (TTM)

HUMA-89.3%

PMVP-87.9%

Earnings Yield (TTM)

HUMA-88.5%

PMVP-92.8%

Dividend Yield (TTM)

HUMAN/A

PMVPN/A

Rule of 40

HUMA-4,440.4

PMVP0.0

EV/GP/RG

HUMAN/A

PMVPN/A

Ticker research

View HUMA research View PMVP research

Metric	HUMA Humacyte Inc	PMVP PMV Pharmaceuticals Inc
Market & Valuation
Market Cap	$109M	$81M
Enterprise Value	$96M	$69M
Price	$0.41	$1.52
P/E Ratio	N/A	N/A
P/S Ratio	51.53x	0.00x
EV/Sales	45.06x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.63x	1.89x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.98x	-0.96x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	14.62x	N/A
Revenue & Growth
Revenue (TTM)	$2M	$0
Revenue Growth (YoY)	159.3%	N/A
Forward Rev Growth	520.3%	546.2%
Profitability
Gross Margin (TTM)	-494.6%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-4900.0%	0.0%
Net Margin (TTM)	-4560.8%	0.0%
FCF Margin (TTM)	-4599.7%	N/A
Net Income (TTM)	$-97M	$-75M
FCF (TTM)	$-98M	$-71M
EPS (TTM)	-$0.41	-$1.41
ROE (TTM)	-51675.0%	-7811.0%
ROA (TTM)	-8476.0%	-7013.0%
ROIC (TTM)	-9784.0%	-7811.0%
Financial Health
Cash	$80M	$12M
Debt	$66M	$0
Net Cash/Debt	$14M	$12M
Current Ratio (TTM)	6.21x	7.70x
Quick Ratio (TTM)	5.38x	7.52x
Debt/Equity (TTM)	2.12x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.76	1.48
52W Performance	-76.0%	7.0%
YTD Performance	-58.4%	23.6%
% from 52W High	-78.6%	-20.4%
% from 52W Low	3.7%	49.0%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.00x
FCF Yield (TTM)	-89.3%	-87.9%
Earnings Yield (TTM)	-88.5%	-92.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-4,440.4	0.0
EV/GP/RG	N/A	N/A
Ticker research	View HUMA research	View PMVP research

Valuation

P/S Ratio

PMVP

0.00x

HUMA

51.53x

EV/FCF

HUMA

-0.98x

PMVP

-0.96x

Growth & revenue

Revenue Growth TTM

HUMA

159.3%

Forward Revenue Growth

PMVP

546.2%

HUMA

520.3%

Profitability & performance

Gross Margin

PMVP

0.0%

HUMA

-494.6%

ROE

PMVP

-7811.0%

HUMA

-51675.0%

FCF Yield %

PMVP

-87.9%

HUMA

-89.3%

52-Week Performance

PMVP

7.0%

HUMA

-76.0%

Detailed metrics comparison

HUMA

Humacyte Inc

PMVP

PMV Pharmaceuticals Inc

Market Cap

HUMA$109M

PMVP$81M

Enterprise Value

HUMA$96M

PMVP$69M

Price

HUMA$0.41

PMVP$1.52

P/E Ratio

HUMAN/A

PMVPN/A

P/S Ratio

HUMA51.53x

PMVP0.00x

EV/Sales

HUMA45.06x

PMVP0.00x

EV/EBITDA

HUMA0.00x

PMVP0.00x

P/B Ratio

HUMA4.63x

PMVP1.89x

P/FCF Ratio

HUMAN/A

PMVPN/A

EV/FCF

HUMA-0.98x

PMVP-0.96x

PEG Ratio

HUMAN/A

PMVPN/A

Forward P/E (NTM)

HUMAN/A

PMVPN/A

Forward P/S (NTM)

HUMA14.62x

PMVPN/A

Revenue (TTM)

HUMA$2M

PMVP$0

Revenue Growth (YoY)

HUMA159.3%

PMVPN/A

Forward Rev Growth

HUMA520.3%

PMVP546.2%

Gross Margin (TTM)

HUMA-494.6%

PMVP0.0%

Operating Margin (TTM)

HUMA0.0%

PMVP0.0%

EBITDA Margin (TTM)

HUMA-4900.0%

PMVP0.0%

Net Margin (TTM)

HUMA-4560.8%

PMVP0.0%

FCF Margin (TTM)

HUMA-4599.7%

PMVPN/A

Net Income (TTM)

HUMA$-97M

PMVP$-75M

FCF (TTM)

HUMA$-98M

PMVP$-71M

EPS (TTM)

HUMA-$0.41

PMVP-$1.41

ROE (TTM)

HUMA-51675.0%

PMVP-7811.0%

ROA (TTM)

HUMA-8476.0%

PMVP-7013.0%

ROIC (TTM)

HUMA-9784.0%

PMVP-7811.0%

Cash

HUMA$80M

PMVP$12M

Debt

HUMA$66M

PMVP$0

Net Cash/Debt

HUMA$14M

PMVP$12M

Current Ratio (TTM)

HUMA6.21x

PMVP7.70x

Quick Ratio (TTM)

HUMA5.38x

PMVP7.52x

Debt/Equity (TTM)

HUMA2.12x

PMVP0.00x

Debt/Assets (TTM)

HUMA0.0%

PMVP0.0%

Interest Coverage (TTM)

HUMAN/A

PMVPN/A

Net Debt/EBITDA (TTM)

HUMA0.00x

PMVP0.00x

Beta

HUMA2.76

PMVP1.48

52W Performance

HUMA-76.0%

PMVP7.0%

YTD Performance

HUMA-58.4%

PMVP23.6%

% from 52W High

HUMA-78.6%

PMVP-20.4%

% from 52W Low

HUMA3.7%

PMVP49.0%

Asset Turnover (TTM)

HUMA0.02x

PMVP0.00x

FCF Yield (TTM)

HUMA-89.3%

PMVP-87.9%

Earnings Yield (TTM)

HUMA-88.5%

PMVP-92.8%

Dividend Yield (TTM)

HUMAN/A

PMVPN/A

Rule of 40

HUMA-4,440.4

PMVP0.0

EV/GP/RG

HUMAN/A

PMVPN/A

Ticker research

View HUMA research View PMVP research

Metric	HUMA Humacyte Inc	PMVP PMV Pharmaceuticals Inc
Market & Valuation
Market Cap	$109M	$81M
Enterprise Value	$96M	$69M
Price	$0.41	$1.52
P/E Ratio	N/A	N/A
P/S Ratio	51.53x	0.00x
EV/Sales	45.06x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.63x	1.89x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.98x	-0.96x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	14.62x	N/A
Revenue & Growth
Revenue (TTM)	$2M	$0
Revenue Growth (YoY)	159.3%	N/A
Forward Rev Growth	520.3%	546.2%
Profitability
Gross Margin (TTM)	-494.6%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-4900.0%	0.0%
Net Margin (TTM)	-4560.8%	0.0%
FCF Margin (TTM)	-4599.7%	N/A
Net Income (TTM)	$-97M	$-75M
FCF (TTM)	$-98M	$-71M
EPS (TTM)	-$0.41	-$1.41
ROE (TTM)	-51675.0%	-7811.0%
ROA (TTM)	-8476.0%	-7013.0%
ROIC (TTM)	-9784.0%	-7811.0%
Financial Health
Cash	$80M	$12M
Debt	$66M	$0
Net Cash/Debt	$14M	$12M
Current Ratio (TTM)	6.21x	7.70x
Quick Ratio (TTM)	5.38x	7.52x
Debt/Equity (TTM)	2.12x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.76	1.48
52W Performance	-76.0%	7.0%
YTD Performance	-58.4%	23.6%
% from 52W High	-78.6%	-20.4%
% from 52W Low	3.7%	49.0%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.00x
FCF Yield (TTM)	-89.3%	-87.9%
Earnings Yield (TTM)	-88.5%	-92.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-4,440.4	0.0
EV/GP/RG	N/A	N/A
Ticker research	View HUMA research	View PMVP research